Clinical Trial Update: Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating procalcitonin to guide antibiotic use in pediatric pneumonia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Respiratory Diseases

Drugs mentioned

• Procalcitonin (procalcitonin)

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Pneumonia, Pediatric Respiratory Diseases | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-02-15